Sign In

Douglas A. Corley, MD, PhD

People

Kaiser Permanente Division of Research
2000 Broadway
Oakland, CA 94612

(510) 891-3811 (phone)
douglas.corley@kp.org
Kaiser Permanente Researcher Profiles


Douglas A. Corley, MD, PhD, MPH, has been a research scientist at the Kaiser Permanente Northern California Division of Research since 2002. He is also a board-certified gastroenterologist who practices at the Kaiser Permanente, San Francisco Medical Center. Dr. Corley’s research interests include outcomes and epidemiologic research in gastroenterology, with a particular emphasis on gastrointestinal cancer epidemiology, cancer surveillance, pharmacoepidemiology, and nutritional epidemiology. Current active research projects include evaluations of Barrett’s esophagus, esophageal adenocarcinoma, gastroesophageal reflux disease, serologic markers for gastrointestinal neoplasia, the long-term effects of gastrointestinal medications (such as anti-acid medications), the intersection between nutrition and gastrointestinal disorders, and the carcinogenic effects of obesity. Dr. Corley is lead investigator for the colon cancer component of the the National Cancer Institute's Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) consortium, a multisite effort to evaluate and improve cancer-screening processes.

After completing medical school at the University of Pennsylvania, Dr. Corley completed an internal medicine residency at the Brigham & Women’s Hospital of the Harvard Medical School in Boston, Massachusetts; and a gastroenterology fellowship at the University of California, San Francisco (UCSF). Dr. Corley subsequently obtained a master’s degree in public health and a doctorate in epidemiology at the University of California, Berkeley, School of Public Health. Prior to joining the Division of Research, he was on the full-time gastroenterology faculty at UCSF, where he was the chief of the UCSF GI Faculty Practice.

Current Position(s):

  • Research Scientist III, Division of Research, Kaiser Permanente Northern California
  • Attending Gastroenterologist, Kaiser Permanente, San Francisco Medical Center
  • Associate Member, University of California, San Francisco Comprehensive Cancer Center
  • Clinical Professor of Medicine, University of California, San Francisco

Section Affiliations:

      Optimizing Colorectal Cancer Screening PREcision and Outcomes in CommunIty-baSEd Populations (PRECISE)

      This study is part of the Population-Based Research Optimizing Screening through Personalized Regimens (PROSPR) program, which aims to enhance understanding of the implementation and effects of screening as practiced in multiple, heterogeneous health care environments in the United States. Within this program, proposed research projects must cover long-term observations of diverse cohorts of patients who are eligible for screening. In addition to observational research to evaluate factors that affect the quality of the screening process, projects must also develop and pilot-test interventions aimed at improving the screening process. This study of colorectal cancer screening precision and outcomes will build upon work completed and in progress from the first five years of PROSPR.
      Investigator: Corley, Douglas
      Funder: National Cancer Institute

      Effectiveness of Screening for Colorectal Cancer in Average Risk Adults: Colonoscopy vs. Fecal Immunochemical Test (FIT)

      This project will evaluate the effectiveness of screening fecal immunochemical testing (FIT) versus screening colonoscopy in reducing the risk of death from colorectal cancer in average risk men and women who receive their care in community settings. We will also develop new statistical methods to account for levels of adherence to recommended screening intervals when comparing tests.
      Investigator: Corley, Douglas
      Funder: National Cancer Institute

      Comprehensive Colorectal Cancer Risk Prediction to Inform Personalized Screening

      The aims of this study are: 1) To build a comprehensive risk-prediction model for colorectal cancer and advanced adenoma in 45,000 colorectal tumors and 45,000 controls based on existing common and rare genome-wide genetic variants, demographic characteristics, and lifestyle and environmental risk factors. 2) To evaluate the risk-prediction models by calibrating and validating the models in the community-based RPGEH cohort and compare it with current screening guidelines and published risk prediction models. 3) To translate abstract risk prediction estimates into individually tailored recommendations that can be used in public health and clinical settings. We will use our developed absolute risk estimates to recommend age to start intervention and the type of screening modality. We will also incorporate a cost-benefit in the decision curve analysis to help clinical decision making.
      Investigator: Corley, Douglas
      Funder: National Cancer Institute

      Kaiser Permanente PROSPR Cervical Cancer Prevention and Screening (CCaPS) Center

      The purpose of this project is to expand PROSPR's activities related to screening women for cervical cancer. PROSPR is the National Cancer Institute's Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) consortium. This specific application will extend an existing collaboration between Kaiser Permanente’s Northern and Southern California regions to include data collection and analyses on cervical cancer with co-principal investigators Michael Silverberg (KPNC) and Chun Chao (KPSC).
      Investigator: Corley, Douglas
      Funder: National Cancer Institute

      Retrospective Validation of MeScore for Identification of Colorectal Cancer

      The purpose of this study is to assess the efficacy of the computational method MeScore CRC in risk stratification for colorectal cancer in a seemingly healthy population (average risk).
      Investigator: Corley, Douglas
      Funder: Medial Research

      Effectiveness of Screening Colonoscopy in Reducing Deaths from Colorectal Cancer (SCOLAR)

      A case-control study to evaluate the associations between commonly performed tests (e.g. colonoscopy) and mortality from colon cancer.
      Investigator: Corley, Douglas
      Funder: National Cancer Institute

      Optimizing Colonoscopy and Fecal Immunochemical Tests for Community-Based Screening, COLOFIT(S)

      An evaluation of the entire colorectal cancer screening process to optimize end results. The study includes evaluation of screen-failures (persons who had cancer detected outside of screening), failures of colonoscopy detection (and causes), and differences between screen detected and non-screen detected cancers.
      Investigator: Corley, Douglas
      Funder: National Cancer Institute

      A New Lab-Based Algorithm for HCC Surveillance in Patients with Cirrhosis

      The objective of this study is to optimize and test the predictive value of a model in predicting the occurrence of HCC and the performance characteristics of cancer screening tests among patients with cirrhosis and hepatitis C infection.
      Investigator: Corley, Douglas
      Funder: National Cancer Institute

      Long-Term, Prospective, Observational Study of the Risk of Cancer Among Pantoprazole (Protonix) Users

      The objective of this study is to determine if there is an increased risk of cancer with pantoprazole (Protonix®), relative to other proton pump inhibitors.
      Investigator: Corley, Douglas
      Funder: Wyeth-Lederle S.p.A.

      Factors Influencing Variation in Physician Adenoma Detection Rates; a Theory-Based Approach for Performance Improvement

      Author(s): Atkins L; Hunkeler EM; Jensen CD; Michie S; Lee JK; Doubeni CA; Zauber AG; Levin TR; Quinn VP; Corley DA

      Gastrointest Endosc. 2015 Sep 11.

      PubMed abstract

      Impact of Endoscopic Surveillance on Mortality from Barrett's Esophagus-Associated Esophageal Adenocarcinomas

      Author(s): Corley DA; Mehtani K; Quesenberry C; Zhao W; de Boer J; Weiss NS

      Gastroenterology. 2013 Aug;145(2):312-9.e1. Epub 2013 May 11.

      PubMed abstract

      Index colonoscopy-related risk factors for postcolonoscopy colorectal cancers.

      Author(s): Tollivoro, Theodore A TA; Jensen, Christopher D CD; Marks, Amy R AR; Zhao, Wei K WK; Schottinger, Joanne E JE; Quinn, Virginia P VP; Ghai, Nirupa R NR; Zauber, Ann G AG; Doubeni, Chyke A CA; Levin, Theodore R TR; Fireman, Bruce B; Quesenberry, Charles P CP; Corley, Douglas A DA

      Gastrointestinal endoscopy. 2018 Aug 22;():. Epub 2018-08-22.

      PubMed abstract

      Overdiagnosis in Colorectal Cancer Screening: Time to Acknowledge a Blind Spot

      Author(s): Kalager M; Wieszczy P; Lansdorp-Vogelaar I; Corley DA; Bretthauer M; Kaminski MF

      Gastroenterology. 2018 Sep;155(3):592-595. Epub 2018-08-01.

      PubMed abstract

      Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large, Community-based Population.

      Author(s): Levin, Theodore R TR; Corley, Douglas A DA; Jensen, Christopher D CD; Schottinger, Joanne E JE; Quinn, Virginia P VP; Zauber, Ann G AG; Lee, Jeffrey K JK; Zhao, Wei K WK; Udaltsova, Natalia N; Ghai, Nirupa R NR; Lee, Alexander T AT; Quesenberry, Charles P CP; Fireman, Bruce H BH; Doubeni, Chyke A CA

      Gastroenterology. 2018 Jul 19;():. Epub 2018-07-19.

      PubMed abstract

      Obesity and renal cell carcinoma risk by histologic subtype: A nested case-control study and meta-analysis

      Author(s): Callahan CL; Hofmann JN; Corley DA; Zhao WK; Shuch B; Chow WH; Purdue MP

      Cancer Epidemiol. 2018 Jul 17;56:31-37. Epub 2018-07-17.

      PubMed abstract

      World Endoscopy Organization Consensus Statements on Post-Colonoscopy and Post-Imaging Colorectal Cancer

      Author(s): Rutter MD; Corley DA; Sanduleanu S; et al.

      Gastroenterology. 2018 Jun 26.

      PubMed abstract

      Health care improvement and survivorship priorities of colorectal cancer survivors: findings from the PORTAL colorectal cancer cohort survey

      Author(s): McMullen C; Corley DA; Feigelson HS; et al.

      Support Care Cancer. 2018 Jun 12.

      PubMed abstract

      Helicobacter pylori Infection Is Associated With Reduced Risk of Barrett's Esophagus: An Analysis of the Barrett's and Esophageal Adenocarcinoma Consortium

      Author(s): Wang Z; Shaheen NJ; Whiteman DC; Anderson LA; Vaughan TL; Corley DA; El-Serag HB; Rubenstein JH; Thrift AP

      Am J Gastroenterol. 2018 Jun 08.

      PubMed abstract

      Timely follow-up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium

      Author(s): Doubeni CA; Corley DA; Armstrong K; et al.

      CA Cancer J Clin. 2018 Mar 30.

      PubMed abstract

      Patterns and predictors or repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States

      Author(s): Singal AG; Corley DA; Halm EA; et al.

      Am J Gastroenterol. 2018 Feb 27.

      PubMed abstract

      Gastroesophageal Reflux Frequency, Severity, Age of Onset, Family History and Acid Suppressive Therapy Predict Barrett Esophagus in a Large Population

      Author(s): Bakr O; Zhao W; Corley D

      J Clin Gastroenterol. 2018 Jan 19.

      PubMed abstract

      Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants

      Author(s): Dong J; Buas MF; Gharahkhani P; Kendall BJ; Onstad L; Zhao S; Anderson LA; Wu AH; Ye W; Bird NC; Bernstein L; Chow WH; Gammon MD; Liu G; Caldas C; Pharoah PD; Risch HA; Iyer PG; Reid BJ; Hardie LJ; Lagergren J; Shaheen NJ; Corley DA; Fitzgerald RC; Stomach and Oesophageal Cancer Study (SOCS) consortium; Whiteman DC; Vaughan TL; Thrift AP

      Gastroenterology. 2017 Dec 13.

      PubMed abstract

      Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study

      Author(s): Rutter CM; Kim JJ; Meester RGS; Sprague BL; Burger EA; Zauber AG; Ergun MA; Campos NG; Doubeni CA; Trentham-Dietz A; Sy S; Alagoz O; Stout N; Lansdorp-Vogelaar I; Corley DA; Tosteson A

      Cancer Epidemiol Biomarkers Prev. 2017 Nov 17.

      PubMed abstract

      The 75th Diamond Anniversary of Gastroenterology: 1943-2018

      Author(s): Peek RM; Corley DA

      Gastroenterology. 2017 Nov 09.

      PubMed abstract

      Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests: A Systematic Review

      Author(s): Selby K; Baumgartner C; Levin TR; Doubeni CA; Zauber AG; Schottinger J; Jensen CD; Lee JK; Corley DA

      Ann Intern Med. 2017 Oct 17;167(8):565-575. Epub 2017-10-10.

      PubMed abstract

      Ethnic disparities in renal cell carcinoma: An analysis of Hispanic patients in a single-payer healthcare system

      Author(s): Suarez-Sarmiento A; Yao X; Hofmann JN; Syed JS; Zhao WK; Purdue MP; Chow WH; Corley D; Shuch B

      Int J Urol. 2017 Sep 15.

      PubMed abstract

      Accurate Identification of Colonoscopy Quality and Polyp Findings Using Natural Language Processing

      Author(s): Lee JK; Jensen CD; Levin TR; Zauber AG; Doubeni CA; Zhao WK; Corley DA

      J Clin Gastroenterol. 2017 Sep 12.

      PubMed abstract

      Dietary sugar/starches intake and Barrett's esophagus: a pooled analysis

      Author(s): Li N; Petrick JL; Steck SE; Bradshaw PT; McClain KM; Niehoff NM; Engel LS; Shaheen NJ; Corley DA; Vaughan TL; Gammon MD

      Eur J Epidemiol. 2017 Sep 01.

      PubMed abstract

      Diagnosis of sessile serrated adenoma after educational training in a large, community-based, integrated healthcare setting

      Author(s): Li D; Woolfrey J; Jiang SF; Jensen CD; Zhao WK; Kakar S; Santamaria M; Rumore G; Armstrong MA; Postlethwaite D; Corley DA; Levin TR

      Gastrointest Endosc. 2017 Aug 23.

      PubMed abstract

      Impact of adenoma detection on the benefit of faecal testing vs. colonoscopy for colorectal cancer

      Author(s): Meester RGS; Doubeni CA; Zauber AG; van Ballegooijen M; Corley DA; Lansdorp-Vogelaar I

      Int J Cancer. 2017 Aug 17.

      PubMed abstract

      Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer: Results From the C SCANS Study

      Author(s): Cespedes Feliciano EM; Kroenke CH; Meyerhardt JA; Prado CM; Bradshaw PT; Kwan ML; Xiao J; Alexeeff S; Corley D; Weltzien E; Castillo AL; Caan BJ

      JAMA Oncol. 2017 Aug 10:e172319.

      PubMed abstract

      Time to Diagnostic Testing After a Positive Colorectal Cancer Screening Test

      Author(s): Doubeni CA; Corley DA; Levin TR

      JAMA. 2017 Aug 01;318(5):483.

      PubMed abstract

      The Troublesome Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma

      Author(s): Schneider JL; Corley DA

      Gastrointest Endosc Clin N Am. 2017 Jul;27(3):353-364.

      PubMed abstract

      Risk of Acute Liver Injury With Antiretroviral Therapy by Viral Hepatitis Status

      Author(s): Gowda C; Newcomb CW; Liu Q; Carbonari DM; Lewis JD; Forde KA; Goldberg DS; Reddy KR; Roy JA; Marks AR; Schneider JL; Kostman JR; Tate JP; Lim JK; Justice AC; Goetz MB; Corley DA; Lo Re V

      Open Forum Infect Dis. 2017 Spring;4(2):ofx012. Epub 2017-01-28.

      PubMed abstract

      Primary care visit use after positive fecal immunochemical test for colorectal cancer screening

      Author(s): Hillyer GC; Jensen CD; Zhao WK; Neugut AI; Lebwohl B; Tiro JA; Kushi LH; Corley DA

      Cancer. 2017 Jun 16.

      PubMed abstract

      Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis.

      Author(s): Corley, Douglas A DA; Jensen, Christopher D CD; Quinn, Virginia P VP; Doubeni, Chyke A CA; Zauber, Ann G AG; Lee, Jeffrey K JK; Schottinger, Joanne E JE; Marks, Amy R AR; Zhao, Wei K WK; Ghai, Nirupa R NR; Lee, Alexander T AT; Contreras, Richard R; Quesenberry, Charles P CP; Fireman, Bruce H BH; Levin, Theodore R TR

      JAMA. 2017 Apr 25;317(16):1631-1641. Epub --.

      PubMed abstract

      Colorectal Cancer Screening Initiation After Age 50 Years in an Organized Program

      Author(s): Fedewa SA; Corley DA; Jensen CD; Zhao W; Goodman M; Jemal A; Ward KC; Levin TR; Doubeni CA

      Am J Prev Med. 2017 Apr 17.

      PubMed abstract

      Racial/ethnic differences in obesity and comorbidities between safety-net- and non safety-net integrated health systems

      Author(s): Balasubramanian BA; Garcia MP; Corley DA; Doubeni CA; Haas JS; Kamineni A; Quinn VP; Wernli K; Zheng Y; Skinner CS

      Medicine (Baltimore). 2017 Mar;96(11):e6326.

      PubMed abstract

      Optimizing patient-reported outcome and risk factor reporting from cancer survivors: a randomized trial of four different survey methods among colorectal cancer survivors

      Author(s): Feigelson HS; McMullen CK; Madrid S; Sterrett AT; Powers JD; Blum-Barnett E; Pawloski PA; Ziegenfuss JY; Quinn VP; Arterburn DE; Corley DA

      J Cancer Surviv. 2017 Jan 13.

      PubMed abstract

      Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative Colorectal Cancer Tissue

      Author(s): Levin TR; Corley DA; Jensen CD; Marks AR; Zhao WK; Zebrowski AM; Quinn VP; Browne LW; Taylor WR; Ahlquist DA; Lidgard GP; Berger BM

      Dig Dis Sci. 2017 Jan 02.

      PubMed abstract

      Proton Pump Inhibitor and Histamine-2 Receptor Antagonist Use and Iron Deficiency

      Author(s): Lam JR; Schneider JL; Quesenberry CP; Corley DA

      Gastroenterology. 2016 Nov 24.

      PubMed abstract

      Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system

      Author(s): Chao C; Silverberg MJ; Becerra TA; Corley DA; Jensen CD; Chen Q; Quinn VP

      Am J Obstet Gynecol. 2017 Feb;216(2):151.e1-151.e9. Epub 2016-10-14.

      PubMed abstract

      Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study

      Author(s): Doubeni CA; Corley DA; Quinn VP; Jensen CD; Zauber AG; Goodman M; Johnson JR; Mehta SJ; Becerra TA; Zhao WK; Schottinger J; Doria-Rose VP; Levin TR; Weiss NS; Fletcher RH

      Gut. 2016 Oct 12.

      PubMed abstract

      Endoscopist Fatigue Estimates and Colonoscopic Adenoma Detection in a Large Community-Based Setting

      Author(s): Lee A; Jensen CD; Marks AR; Zhao WK; Doubeni CA; Zauber AG; Quinn VP; Levin TR; Corley DA

      Gastrointest Endosc. 2017 Mar;85(3):601-610.e2. Epub 2016-10-01.

      PubMed abstract

      Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus

      Author(s): Thrift AP; Anderson LA; Murray LJ; Cook MB; Shaheen NJ; Rubenstein JH; El-Serag HB; Vaughan TL; Schneider JL; Whiteman DC; Corley DA

      Am J Gastroenterol. 2016 Aug 30.

      PubMed abstract

      Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis

      Author(s): Gharahkhani P; Fitzgerald RC; Vaughan TL; Palles C; Gockel I; Tomlinson I; Buas MF; May A; Gerges C; Anders M; Becker J; Kreuser N; Noder T; Venerito M; Veits L; Schmidt T; Manner H; Schmidt C; Hess T; B?hmer AC; Izbicki JR; H?lscher AH; Lang H; Lorenz D; Schumacher B; Hackelsberger A; Mayershofer R; Pech O; Vashist Y; Ott K; Vieth M; Weism?ller J; N?then MM; Barrett's and Esophageal Adenocarcinoma Consortium (BEACON); Esophageal Adenocarcinoma GenEtics Consortium (EAGLE); Wellcome Trust Case Control Consortium 2 (WTCCC2); Attwood S; Barr H; Chegwidden L; de Caestecker J; Harrison R; Love SB; MacDonald D; Moayyedi P; Prenen H; Watson RG; Iyer PG; Anderson LA; Bernstein L; Chow WH; Hardie LJ; Lagergren J; Liu G; Risch HA; Wu AH; Ye W; Bird NC; Shaheen NJ; Gammon MD; Corley DA; Caldas C; Moebus S; Knapp M; Peters WH; Neuhaus H; R?sch T; Ell C; MacGregor S; Pharoah P; Whiteman DC; Jankowski J; Schumacher J

      Lancet Oncol. 2016 Aug 12.

      PubMed abstract

      Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma

      Author(s): Buas MF; He Q; Johnson LG; Onstad L; Levine DM; Thrift AP; Gharahkhani P; Palles C; Lagergren J; Fitzgerald RC; Ye W; Caldas C; Bird NC; Shaheen NJ; Bernstein L; Gammon MD; Wu AH; Hardie LJ; Pharoah PD; Liu G; Iyer P; Corley DA; Risch HA; Chow WH; Prenen H; Chegwidden L; Love S; Attwood S; Moayyedi P; MacDonald D; Harrison R; Watson P; Barr H; deCaestecker J; Tomlinson I; Jankowski J; Whiteman DC; MacGregor S; Vaughan TL; Madeleine MM

      Gut. 2016 Aug 2.

      PubMed abstract

      Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System

      Author(s): Mehta SJ; Jensen CD; Quinn VP; Schottinger JE; Zauber AG; Meester R; Laiyemo AO; Fedewa S; Goodman M; Fletcher RH; Levin TR; Corley DA; Doubeni CA

      J Gen Intern Med. 2016 Jul 13.

      PubMed abstract

      Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma

      Author(s): Wennerström EC; Risques RA; Prunkard D; Giffen C; Corley DA; Murray LJ; Whiteman DC; Wu AH; Bernstein L; Ye W; Chow WH; Vaughan TL; Liao LM

      Cancer Med. 2016 Jul 6.

      PubMed abstract

      Prevention of Vertical Transmission of Hepatitis B: An Observational Study

      Author(s): Kubo A; Shlager L; Marks AR; Lakritz D; Beaumont C; Gabellini K; Corley DA

      Ann Intern Med. 2014 Jun 17;160(12):828-35.

      PubMed abstract

      Influence of Age and Comorbidity on Colorectal Cancer Screening in the Elderly

      Author(s): Klabunde CN; Zheng Y; Quinn VP; Beaber EF; Rutter CM; Halm EA; Chubak J; Doubeni CA; Haas JS; Kamineni A; Schapira MM; Vacek PM; Garcia MP; Corley DA; PROSPR consortium

      Am J Prev Med. 2016 Jun 15.

      PubMed abstract

      Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach

      Author(s): Halm EA; Beaber EF; McLerran D; Chubak J; Corley DA; Rutter CM; Doubeni CA; Haas JS; Balasubramanian BA

      J Gen Intern Med. 2016 Jun 8.

      PubMed abstract

      Inverse Association Between Gluteofemoral Obesity and Risk of Barrett's Esophagus in a Pooled Analysis

      Author(s): Kendall BJ; Rubenstein JH; Cook MB; Vaughan TL; Anderson LA; Murray LJ; Shaheen NJ; Corley DA; Chandar AK; Li L; Greer KB; Chak A; El-Serag HB; Whiteman DC; Thrift AP

      Clin Gastroenterol Hepatol. 2016 Jun 2.

      PubMed abstract

      Racial disparities in renal cell carcinoma: a single-payer healthcare experience

      Author(s): Mafolasire A; Yao X; Nawaf C; Suarez-Sarmiento A; Chow WH; Zhao W; Corley D; Hofmann JN; Purdue M; Adeniran AJ; Shuch B

      Cancer Med. 2016 May 26.

      PubMed abstract

      The Dawning of a New Editorial Board for Gastroenterology

      Author(s): Corley DA; Peek RM

      Gastroenterology. 2016 May 20.

      PubMed abstract

      Consequences of Increasing Time to Colonoscopy Examination Following Positive Result From Fecal Colorectal Cancer Screening Test

      Author(s): Meester RG; Zauber AG; Doubeni CA; Jensen CD; Quinn VP; Helfand M; Dominitz JA; Levin TR; Corley DA; Lansdorp-Vogelaar I

      Clin Gastroenterol Hepatol. 2016 May 19.

      PubMed abstract

      Reply

      Author(s): Lo Re V; Forde KA; Goldberg DS; Lewis JD; Carbonari DM; Reddy KR; Roy J; Sha D; Strom BL; Corley DA

      Clin Gastroenterol Hepatol. 2016 Feb 12.

      PubMed abstract

      Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study

      Author(s): Jensen CD; Corley DA; Quinn VP; Doubeni CA; Zauber AG; Lee JK; Zhao WK; Marks AR; Schottinger JE; Ghai NR; Lee AT; Contreras R; Klabunde CN; Quesenberry CP; Levin TR; Mysliwiec PA

      Ann Intern Med. 2016 Apr 5;164(7):456-63. Epub 2016-01-26.

      PubMed abstract

      What makes a "good" colonoscopy quality indicator?

      Author(s): Lee JK; Corley DA

      Gastrointest Endosc. 2016 Jan;83(1):179-81.

      PubMed abstract

      Fecal Immunochemical Test (FIT) for Colon Cancer Screening: Variable Performance with Ambient Temperature

      Author(s): Doubeni CA; Jensen CD; Fedewa SA; Quinn VP; Zauber AG; Schottinger JE; Corley DA; Levin TR

      J Am Board Fam Med. 2016 11/12;29(6):672-681.

      PubMed abstract

      Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium

      Author(s): Tosteson AN; Beaber EF; Tiro J; Kim J; McCarthy AM; Quinn VP; Doria-Rose VP; Wheeler CM; Barlow WE; Bronson M; Garcia M; Corley DA; Haas JS; Halm EA; Kamineni A; Rutter CM; Tosteson TD; Trentham-Dietz A; Weaver DL; PROSPR consortium

      J Gen Intern Med. 2015 Dec 9.

      PubMed abstract

      Oral Azole Antifungal Medications and Risk of Acute Liver Injury, Overall and by Chronic Liver Disease Status

      Author(s): Lo Re V; Carbonari DM; Lewis JD; Forde KA; Goldberg DS; Reddy KR; Haynes K; Roy JA; Sha D; Marks AR; Schneider JL; Strom BL; Corley DA

      Am J Med. 2015 Nov 17.

      PubMed abstract

      Risk of gastric cancer, gastrointestinal cancers and other cancers: a comparison of treatment with pantoprazole and other proton pump inhibitors

      Author(s): Schneider JL; Kolitsopoulos F; Corley DA

      Aliment Pharmacol Ther. 2015 Nov 6.

      PubMed abstract

      Oral Bisphosphonate Exposure and the Risk of Upper Gastrointestinal Cancers

      Author(s): Vogtmann E; Corley DA; Almers LM; Cardwell CR; Murray LJ; Abnet CC

      PLoS ONE. 2015;10(10):e0140180. Epub 2015-10-07.

      PubMed abstract

      Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinoma

      Author(s): Ek WE; Lagergren K; Cook M; Wu AH; Abnet CC; Levine D; Chow WH; Bernstein L; Risch HA; Shaheen NJ; Bird NC; Corley DA; Hardie LJ; Fitzgerald RC; Gammon MD; Romero Y; Liu G; Ye W; Vaughan TL; MacGregor S; Whiteman DC; Westberg L; Lagergren J

      Int J Cancer. 2015 Sep 28.

      PubMed abstract

      Polymorphisms in Genes of Relevance for Oestrogen and Oxytocin Pathways and Risk of Barrett's Oesophagus and Oesophageal Adenocarcinoma: A Pooled Analysis from the BEACON Consortium

      Author(s): Lagergren K; Ek WE; Levine D; Chow WH; Bernstein L; Casson AG; Risch HA; Shaheen NJ; Bird NC; Reid BJ; Corley DA; Hardie LJ; Wu AH; Fitzgerald RC; Pharoah P; Caldas C; Romero Y; Vaughan TL; MacGregor S; Whiteman D; Westberg L; Nyren O; Lagergren J

      PLoS ONE. 2015;10(9):e0138738. Epub 2015-09-25.

      PubMed abstract

      Ghrelin and Leptin Have a Complex Relationship with Risk of Barrett's Esophagus

      Author(s): Thomas SJ; Almers L; Schneider J; Graham JE; Havel PJ; Corley DA

      Dig Dis Sci. 2015 Sep 22.

      PubMed abstract

      A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus

      Author(s): Dai JY; Tapsoba JD; Buas MF; Onstad LE; Levine DM; Risch HA; Chow WH; Bernstein L; Ye W; Lagergren J; Bird NC; Corley DA; Shaheen NJ; Wu AH; Reid BJ; Hardie LJ; Whiteman DC; Vaughan TL

      Cancer Epidemiol Biomarkers Prev. 2015 Sep 16.

      PubMed abstract

      Metformin Use and Risk of Colorectal Adenoma After Polypectomy in Patients with Type 2 Diabetes Mellitus

      Author(s): Marks AR; Pietrofesa RA; Jensen CD; Zebrowski A; Corley DA; Doubeni CA

      Cancer Epidemiol Biomarkers Prev. 2015 Sep 16.

      PubMed abstract

      Pleiotropic analysis of cancer risk loci on esophageal adenocarcinoma risk

      Author(s): Lee E; Stram DO; Ek WE; Onstad LE; Macgregor S; Gharahkhani P; Ye W; Lagergren J; Shaheen NJ; Murray LJ; Hardie LJ; Gammon MD; Chow WH; Risch HA; Corley DA; Levine DM; Whiteman DC; Bernstein L; Bird NC; Vaughan TL; Wu AH

      Cancer Epidemiol Biomarkers Prev. 2015 Sep 12.

      PubMed abstract

      Factors Influencing Variation in Physician Adenoma Detection Rates; a Theory-Based Approach for Performance Improvement

      Author(s): Atkins L; Hunkeler EM; Jensen CD; Michie S; Lee JK; Doubeni CA; Zauber AG; Levin TR; Quinn VP; Corley DA

      Gastrointest Endosc. 2015 Sep 11.

      PubMed abstract

      Quality Indicators for the Management of Barrett's Esophagus, Dysplasia and Esophageal Adenocarcinoma: International Consensus Recommendations from AGA Symposium

      Author(s): Sharma P; Katzka D; Gupta N; Ajani J; Buttar N; Chak A; Corley D; El-Serag H; Falk GW; Fitzgerald R; Goldblum J; Gress F; Ilson DH; Inadomi JM; Kuipers EJ; Lynch JP; McKeon F; Metz D; Pasricha PJ; Pech O; Peek R; Peters JH; Repici A; Seewald S; Shaheen NJ; Souza RF; Spechler SJ; Vennalaganti P; Wang K

      Gastroenterology. 2015 Aug 18.

      PubMed abstract

      Observational methods to assess the effectiveness of screening colonoscopy in reducing right colon cancer mortality risk: SCOLAR

      Author(s): Goodman M; Fletcher RH; Doria-Rose VP; Jensen CD; Zebrowski AM; Becerra TA; Quinn VP; Zauber AG; Corley DA; Doubeni CA

      J Comp Eff Res. 2015 Jul 23:1-11.

      PubMed abstract

      The authors respond: Differences in 25-hydroxyvitamin D concentrations may explain the black-white differences in chronic kidney disease and risk of renal cell carcinoma

      Author(s): Hofmann JN; Corley DA; Colt JS; Shuch B; Chow WH; Purdue MP

      Epidemiology. 2015 Jul;26(4):e49.

      PubMed abstract

      Risk of Acute Liver Failure in Patients with Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic Model

      Author(s): Lo Re V; Haynes K; Forde KA; Goldberg DS; Lewis JD; Carbonari DM; Leidl KB; Reddy KR; Nezamzadeh MS; Roy J; Sha D; Marks AR; De Boer J; Schneider JL; Strom BL; Corley DA

      Clin Gastroenterol Hepatol. 2015 Jun 26.

      PubMed abstract

      Variation in Adenoma Detection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening; A Microsimulation Model

      Author(s): Meester RG; Doubeni CA; Lansdorp-Vogelaar I; Jensen CD; van der Meulen MP; Levin TR; Quinn VP; Schottinger JE; Zauber AG; Corley DA; van Ballegooijen M

      JAMA. 2015 Jun 16;313(23):2349-58.

      PubMed abstract

      MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium

      Author(s): Buas MF; Onstad L; Levine DM; Risch HA; Chow WH; Liu G; Fitzgerald RC; Bernstein L; Ye W; Bird NC; Romero Y; Casson AG; Corley DA; Shaheen NJ; Wu AH; Gammon MD; Reid BJ; Hardie LJ; Peters U; Whiteman DC; Vaughan TL

      PLoS ONE. 2015;10(6):e0128617. Epub 2015-06-03.

      PubMed abstract

      Population-representative Incidence of Drug-induced Acute Liver Failure Based on an Analysis of an Integrated Healthcare System

      Author(s): Goldberg DS; Forde KA; Carbonari DM; Lewis JD; Leidl KB; Reddy KR; Haynes K; Roy J; Sha D; Marks AR; Schneider JL; Strom BL; Corley DA; Lo Re V

      Gastroenterology. 2015 Jun;148(7):1353-61.e3. Epub 2015-02-28.

      PubMed abstract

      Building Data Infrastructure to Evaluate and Improve Quality: PCORnet

      Author(s): Corley DA; Feigelson HS; Lieu TA; McGlynn EA

      J Oncol Pract. 2015 May;11(3):204-6.

      PubMed abstract

      Diet and Upper Gastrointestinal Malignancies

      Author(s): Abnet CC; Corley DA; Freedman ND; Kamangar F

      Gastroenterology. 2015 May;148(6):1234-1243.e4. Epub 2015-02-11.

      PubMed abstract

      Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018

      Author(s): Meester RG; Doubeni CA; Zauber AG; Goede SL; Levin TR; Corley DA; Jemal A; Lansdorp-Vogelaar I

      Cancer. 2015 Mar 12.

      PubMed abstract

      Colorectal cancer deaths attributable to nonuse of screening in the United States

      Author(s): Meester RG; Doubeni CA; Lansdorp-Vogelaar I; Goede SL; Levin TR; Quinn VP; Ballegooijen Mv; Corley DA; Zauber AG

      Ann Epidemiol. 2015 Mar;25(3):208-213.e1. Epub 2014-12-05.

      PubMed abstract

      Development and validation of an algorithm for classifying colonoscopy indication

      Author(s): Lee JK; Jensen CD; Lee A; Doubeni CA; Zauber AG; Levin TR; Zhao WK; Corley DA

      Gastrointest Endosc. 2015 Mar;81(3):575-582.e4. Epub 2015-01-08.

      PubMed abstract

      Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett's Esophagus

      Author(s): Palles C; Chegwidden L; Li X; Findlay JM; Farnham G; Castro Giner F; Peppelenbosch MP; Kovac M; Adams CL; Prenen H; Briggs S; Harrison R; Sanders S; MacDonald D; Haigh C; Tucker A; Love S; Nanji M; deCaestecker J; Ferry D; Rathbone B; Hapeshi J; Barr H; Moayyedi P; Watson P; Zietek B; Maroo N; Gay L; Underwood T; Boulter L; McMurtry H; Monk D; Patel P; Ragunath K; Al Dulaimi D; Murray I; Koss K; Veitch A; Trudgill N; Nwokolo C; Rembacken B; Atherfold P; Green E; Ang Y; Kuipers EJ; Chow W; Paterson S; Kadri S; Beales I; Grimley C; Mullins P; Beckett C; Farrant M; Dixon A; Kelly S; Johnson M; Wajed S; Dhar A; Sawyer E; Roylance R; Onstad L; Gammon MD; Corley DA; Shaheen NJ; Bird NC; Hardie LJ; Reid BJ; Ye W; Liu G; Romero Y; Bernstein L; Wu AH; Casson AG; Fitzgerald R; Whiteman DC; Risch HA; Levine DM; Vaughan TL; Verhaar AP; van den Brande J; Toxopeus EL; Spaander MC; Wijnhoven BP; van der Laan LJ; Krishnadath K; Wijmenga C; Trynka G; McManus R; Reynolds JV; O'Sullivan J; MacMathuna P; McGarrigle SA; Kelleher D; Vermeire S; Cleynen I; Bisschops R; Tomlinson I; Jankowski J

      Gastroenterology. 2015 Feb;148(2):367-78. Epub 2014-11-05.

      PubMed abstract

      A review of the epidemiology of Barrett's oesophagus and oesophageal adenocarcinoma

      Author(s): Schneider JL; Corley DA

      Best Pract Res Clin Gastroenterol. 2015 Feb;29(1):29-39. Epub 2014-12-03.

      PubMed abstract

      Aspirin and Nonsteroidal Anti-Inflammatory Drug Use and the Risk of Barrett's Esophagus

      Author(s): Schneider JL; Zhao WK; Corley DA

      Dig Dis Sci. 2015 Feb;60(2):436-43. Epub 2014-09-12.

      PubMed abstract

      Adiponectin may modify the risk of Barrett's esophagus in patients with gastroesophageal reflux disease

      Author(s): Almers LM; Graham JE; Havel PJ; Corley DA

      Clin Gastroenterol Hepatol. 2015 Jan 26.

      PubMed abstract

      Imputation of the Rare HOXB13 G84E Mutation and Cancer Risk in a Large Population-Based Cohort

      Author(s): Hoffmann TJ; Sakoda LC; Shen L; Jorgenson E; Habel LA; Liu J; Kvale MN; Asgari MM; Banda Y; Corley D; Kushi LH; Quesenberry CP; Schaefer C; Van Den Eeden SK; Risch N; Witte JS

      PLoS Genet. 2015 Jan;11(1):e1004930. Epub 2015-01-28.

      PubMed abstract

      Chronic Kidney Disease and Risk of Renal Cell Carcinoma: Differences by Race

      Author(s): Hofmann JN; Corley DA; Zhao WK; Colt JS; Shuch B; Chow WH; Purdue MP

      Epidemiology. 2015 Jan;26(1):59-67.

      PubMed abstract

      Does Human Papillomavirus Cause Esophageal Adenocarcinoma?

      Author(s): Corley D

      Clin Gastroenterol Hepatol. 2014 Dec 24.

      PubMed abstract

      Importance of determining indication for colonoscopy: implications for practice and policy original

      Author(s): Singal AG; Gupta S; Lee J; Halm EA; Rutter CM; Corley D; Inadomi J

      Clin Gastroenterol Hepatol. 2014 Dec;12(12):1958-63.e1-3.

      PubMed abstract

      Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma

      Author(s): Buas MF; Levine DM; Makar KW; Utsugi H; Onstad L; Li X; Galipeau PC; Shaheen NJ; Hardie LJ; Romero Y; Bernstein L; Gammon MD; Casson AG; Bird NC; Risch HA; Ye W; Liu G; Corley DA; Blount PL; Fitzgerald RC; Whiteman DC; Wu AH; Reid BJ; Vaughan TL

      Carcinogenesis. 2014 Dec;35(12):2740-7. Epub 2014-10-03.

      PubMed abstract

      Assessing bowel preparation quality using the mean number of adenomas per colonoscopy

      Author(s): Hillyer GC; Lebwohl B; Rosenberg RM; Neugut AI; Wolf R; Basch CH; Mata J; Hernandez E; Corley DA; Shea S; Basch CE

      Therap Adv Gastroenterol. 2014 Nov;7(6):238-46.

      PubMed abstract

      Obesity and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus: A Mendelian Randomization Study

      Author(s): Thrift AP; Shaheen NJ; Gammon MD; Bernstein L; Reid BJ; Onstad L; Risch HA; Liu G; Bird NC; Wu AH; Corley DA; Romero Y; Chanock SJ; Chow WH; Casson AG; Levine DM; Zhang R; Ek WE; MacGregor S; Ye W; Hardie LJ; Vaughan TL; Whiteman DC

      J Natl Cancer Inst. 2014 Nov;106(11). Epub 2014-09-30.

      PubMed abstract

      Adjusting for Patient Demographics Has Minimal Effects on Rates of Adenoma Detection in a Large, Community-based Setting

      Author(s): Jensen CD; Doubeni CA; Quinn VP; Levin TR; Zauber AG; Schottinger JE; Marks AR; Zhao WK; Lee JK; Ghai NR; Schneider JL; Fireman BH; Quesenberry CP; Corley DA

      Clin Gastroenterol Hepatol. 2015 Apr;13(4):739-46. Epub 2014-10-25.

      PubMed abstract

      Risk of Esophageal Adenocarcinoma Decreases with Height, Based on Consortium Analysis and Confirmed by Mendelian Randomization

      Author(s): Thrift AP; Risch HA; Onstad L; Shaheen NJ; Casson AG; Bernstein L; Corley DA; Levine DM; Chow WH; Reid BJ; Romero Y; Hardie LJ; Liu G; Wu AH; Bird NC; Gammon MD; Ye W; Whiteman DC; Vaughan TL

      Clin Gastroenterol Hepatol. 2014 Oct;12(10):1667-76.e1. Epub 2014-02-12.

      PubMed abstract

      Alcohol and the Risk of Barrett's Esophagus: A Pooled Analysis from the International BEACON Consortium

      Author(s): Thrift AP; Cook MB; Vaughan TL; Anderson LA; Murray LJ; Whiteman DC; Shaheen NJ; Corley DA

      Am J Gastroenterol. 2014 Oct;109(10):1586-94. Epub 2014-07-22.

      PubMed abstract

      Dietary guideline adherence for gastroesophageal reflux disease

      Author(s): Kubo A; Block G; Quesenberry CP; Buffler P; Corley DA

      BMC Gastroenterol. 2014;14:144. Epub 2014-08-14.

      PubMed abstract

      Gastroesophageal Reflux in Relation to Adenocarcinomas of the Esophagus: A Pooled Analysis from the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON)

      Author(s): Cook MB; Corley DA; Murray LJ; Liao LM; Kamangar F; Ye W; Gammon MD; Risch HA; Casson AG; Freedman ND; Chow WH; Wu AH; Bernstein L; Nyrén O; Pandeya N; Whiteman DC; Vaughan TL

      PLoS ONE. 2014;9(7):e103508. Epub 2014-07-30.

      PubMed abstract

      Multitarget stool DNA testing for colorectal-cancer screening.

      Author(s): Lee, Jeffrey K JK; Terdiman, Jonathan P JP; Corley, Douglas A DA

      The New England journal of medicine. 2014 07 10;371(2):186. Epub --.

      PubMed abstract

      Developing a data infrastructure for a learning health system: the PORTAL network

      Author(s): McGlynn EA; Lieu TA; Durham ML; Bauck A; Laws R; Go AS; Chen J; Feigelson HS; Corley DA; Young DR; Nelson AF; Davidson AJ; Morales LS; Kahn MG

      J Am Med Inform Assoc. 2014 Jul-Aug;21(4):596-601. Epub 2014-05-12.

      PubMed abstract

      The Colorectal Cancer Screening Process in Community Settings: A Conceptual Model for the Population-Based Research Optimizing Screening through Personalized Regimens Consortium

      Author(s): Tiro JA; Kamineni A; Levin TR; Zheng Y; Schottinger JS; Rutter CM; Corley DA; Skinner CS; Chubak J; Doubeni CA; Halm EA; Gupta S; Wernli KJ; Klabunde C

      Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1147-58. Epub 2014-06-10.

      PubMed abstract

      Aspirin and non-aspirin NSAIDs increase risk of colonic diverticular bleeding: a systematic review and meta-analysis

      Author(s): Yuhara H; Corley DA; Nakahara F; Nakajima T; Koike J; Igarashi M; Suauki T; Mine T

      J Gastroenterol. 2014 Jun;49(6):992-1000. Epub 2013-11-14.

      PubMed abstract

      Gastric acid-inhibiting medications and vitamin B12 deficiency--reply

      Author(s): Corley D; Lam J; Schneider J

      JAMA. 2014 Apr 9;311(14):1445-6.

      PubMed abstract

      Adenoma detection rate and risk of colorectal cancer and death

      Author(s): Corley DA; Jensen CD; Marks AR; Zhao WK; Lee JK; Doubeni CA; Zauber AG; de Boer J; Fireman BH; Schottinger JE; Quinn VP; Ghai NR; Levin TR; Quesenberry CP

      N Engl J Med. 2014 Apr 3;370(14):1298-306.

      PubMed abstract

      Approaches for classifying the indications for colonoscopy using detailed clinical data

      Author(s): Fassil H; Adams KF; Weinmann S; Doria-Rose VP; Johnson E; Williams AE; Corley DA; Doubeni CA

      BMC Cancer. 2014;14:95. Epub 2014-02-15.

      PubMed abstract

      Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis

      Author(s): Lee JK; Liles EG; Bent S; Levin TR; Corley DA

      Ann Intern Med. 2014 Feb 4;160(3):171.

      PubMed abstract

      Reply: Implementation of new knowledge, technique, and technology to survey Barrett's is urgently needed.

      Author(s): Corley DA

      Gastroenterology. 2014 Feb;146(2):588-9. Epub 2013-12-19.

      PubMed abstract

      Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency

      Author(s): Lam JR; Schneider JL; Zhao W; Corley DA

      JAMA. 2013 Dec 11;310(22):2435-42.

      PubMed abstract

      Uncontrolled confounding in studies of screening effectiveness: an example of colonoscopy

      Author(s): Eldridge RC; Doubeni CA; Fletcher RH; Zauber AG; Corley DA; Doria-Rose VP; Goodman M

      J Med Screen. 2013 Dec;20(4):198-207. Epub 2013-10-21.

      PubMed abstract

      Sex-specific associations between body mass index, waist circumference and the risk of Barrett's oesophagus: a pooled analysis from the international BEACON consortium

      Author(s): Kubo A; Cook MB; Shaheen NJ; Vaughan TL; Whiteman DC; Murray L; Corley DA

      Gut. 2013 Dec;62(12):1684-91.

      PubMed abstract

      A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus

      Author(s): Levine DM; Ek WE; Zhang R; Liu X; Onstad L; Sather C; Lao-Sirieix P; Gammon MD; Corley DA; Shaheen NJ; Bird NC; Hardie LJ; Murray LJ; Reid BJ; Chow WH; Risch HA; Nyrén O; Ye W; Liu G; Romero Y; Bernstein L; Wu AH; Casson AG; Chanock SJ; Harrington P; Caldas I; Debiram-Beecham I; Caldas C; Hayward NK; Pharoah PD; Fitzgerald RC; Macgregor S; Whiteman DC; Vaughan TL

      Nat Genet. 2013 Dec;45(12):1487-93. Epub 2013-10-13.

      PubMed abstract

      Germline Genetic Contributions to Risk for Esophageal Adenocarcinoma, Barrett's Esophagus, and Gastroesophageal Reflux

      Author(s): Ek WE; Levine DM; D'Amato M; Pedersen NL; Magnusson PK; Bresso F; Onstad LE; Schmidt PT; Tornblom H; Nordenstedt H; Romero Y; Mayo Clinic Esophageal Adenocarcinoma and Barrett's Esophagus Registry Consortium; Chow WH; Murray LJ; Gammon MD; Liu G; Bernstein L; Casson AG; Risch HA; Shaheen NJ; Bird NC; Reid BJ; Corley DA; Hardie LJ; Ye W; Wu AH; Zucchelli M; Spector TD; Hysi P; Vaughan TL; Whiteman DC; MacGregor S; BEACON study investigators

      J Natl Cancer Inst. 2013 Nov 20;105(22):1711-8. Epub 2013-10-29.

      PubMed abstract

      Impact of Endoscopic Surveillance on Mortality from Barrett's Esophagus-Associated Esophageal Adenocarcinomas

      Author(s): Corley DA; Mehtani K; Quesenberry C; Zhao W; de Boer J; Weiss NS

      Gastroenterology. 2013 Aug;145(2):312-9.e1. Epub 2013 May 11.

      PubMed abstract

      Can You Stop Surveillance After Radiofrequency Ablation of Barrett's Esophagus? A Glass Half Full

      Author(s): Corley DA

      Gastroenterology. 2013 Jul;145(1):39-42.

      PubMed abstract

      Dietary fiber and the risk of precancerous lesions and cancer of the esophagus: a systematic review and meta-analysis

      Author(s): Coleman HG; Murray LJ; Hicks B; Bhat SK; Kubo A; Corley DA; Cardwell CR; Cantwell MM

      Nutr Rev. 2013 Jul;71(7):474-82. Epub 2013 Apr 24.

      PubMed abstract

      Meta-analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease

      Author(s): Yuhara H; Steinmaus C; Corley D; Koike J; Igarashi M; Suzuki T; Mine T

      Aliment Pharmacol Ther. 2013 May;37(10):953-62.

      PubMed abstract

      Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study

      Author(s): Doubeni CA; Weinmann S; Adams K; Kamineni A; Buist DS; Ash AS; Rutter CM; Doria-Rose VP; Corley DA; Greenlee RT; Chubak J; Williams A; Kroll-Desrosiers AR; Johnson E; Webster J; Richert-Boe K; Levin TR; Fletcher RH; Weiss NS

      Ann Intern Med. 2013 Mar 5;158(5 Pt 1):312-20.

      PubMed abstract

      The road ahead: what if gastroenterologists were accountable for preventing colorectal cancer?

      Author(s): Lee, Jeffrey K JK; Levin, Theodore R TR; Corley, Douglas A DA

      Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2013 Mar ;11(3):204-7. Epub --.

      PubMed abstract

      Variation of Adenoma Prevalence by Age, Sex, Race, and Colon Location in a Large Population: Implications for Screening and Quality Programs

      Author(s): Corley DA; Jensen CD; Marks AR; Zhao WK; de Boer J; Levin TR; Doubeni C; Fireman BH; Quesenberry CP

      Clin Gastroenterol Hepatol. 2013 Feb;11(2):172-80. Epub 2012 Sep 14.

      PubMed abstract

      Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium

      Author(s): Hoyo C; Cook MB; Kamangar F; Freedman ND; Whiteman DC; Bernstein L; Brown LM; Risch HA; Ye W; Sharp L; Wu AH; Ward MH; Casson AG; Murray LJ; Corley DA; Nyren O; Pandeya N; Vaughan TL; Chow WH; Gammon MD

      Int J Epidemiol. 2012 Dec;41(6):1706-18. Epub 2012 Nov 12.

      PubMed abstract

      A Combination of Esomeprazole and Aspirin Reduce Tissue Concentrations of Prostaglandin E2 in Patients with Barrett's Esophagus

      Author(s): Falk GW; Buttar NS; Foster NR; Demars CJ; Romero Y; Marcon NE; Schnell T; Corley DA; Sharma P; Cruz-Correa MR; Hur C; Fleischer DE; Chak A; Devault KR; Weinberg DS; Richmond E; Smyrk TC; Mandrekar SJ; Limburg PJ; Cancer Prevention Network; Ziegler KL; Della'Zanna G

      Gastroenterology. 2012 Oct;143(4):917-26.e1. Epub 2012 Jul 11.

      PubMed abstract

      Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus

      Author(s): Su Z; Gay LJ; Strange A; Palles C; Band G; Whiteman DC; Lescai F; Langford C; Nanji M; Edkins S; van der Winkel A; Levine D; Sasieni P; Bellenguez C; Howarth K; Freeman C; Trudgill N; Tucker AT; Pirinen M; Peppelenbosch MP; van der Laan LJ; Kuipers EJ; Drenth JP; Peters WH; Reynolds JV; Kelleher DP; McManus R; Grabsch H; Prenen H; Bisschops R; Krishnadath K; Siersema PD; van Baal JW; Middleton M; Petty R; Gillies R; Burch N; Bhandari P; Paterson S; Edwards C; Penman I; Vaidya K; Ang Y; Murray I; Patel P; Ye W; Mullins P; Wu AH; Bird NC; Dallal H; Shaheen NJ; Murray LJ; Koss K; Bernstein L; Romero Y; Hardie LJ; Zhang R; Winter H; Corley DA; Panter S; Risch HA; Reid BJ; Sargeant I; Gammon MD; Smart H; Dhar A; McMurtry H; Ali H; Liu G; Casson AG; Chow WH; Rutter M; Tawil A; Morris D; Nwokolo C; Isaacs P; Rodgers C; Ragunath K; Haigh C; Monk D; Davies G; Wajed S; Johnston D; Gibbons M; Cullen S; Church N; Langley R; Griffin M; Alderson D; Deloukas P; Hunt SE; Gray E; Dronov S; Potter SC; Tashakkori-Ghanbaria A; Anderson M; Brooks C; Blackwell JM; Bramon E; Brown MA; Casas JP; Corvin A; Duncanson A; Markus HS; Mathew CG; Palmer CN; Plomin R; Rautanen A; Sawcer SJ; Trembath RC; Viswanathan AC; Wood N; Trynka G; Wijmenga C; Cazier JB; Atherfold P; Nicholson AM; Gellatly NL; Glancy D; Cooper SC; Cunningham D; Lind T; Hapeshi J; Ferry D; Rathbone B; Brown J; Love S; Attwood S; Watson P; Sanders S; Ek W; Harrison RF; Moayyedi P; de Caestecker J; Barr H; Stupka E; Vaughan TL; Peltonen L; Spencer CC; Tomlinson I; Donnelly P; Jankowski JA; MacDonald C; MacGregor S; Esophageal Adenocarcinoma Genetics Consortium; Wellcome Trust Case Control Consortium 2

      Nat Genet. 2012 Oct;44(10):1131-6. Epub 2012 Sep 9.

      PubMed abstract

      Barrett's Esophagus: Who Should Receive Ablation and How Can We Get the Best Results?

      Author(s): Corley DA; Bergman JJ

      Gastroenterology. 2012 Sep;143(3):524-6. Epub 2012 Jul 25.

      PubMed abstract

      Consensus Statements for Management of Barrett's Dysplasia and Early-Stage Esophageal Adenocarcinoma, Based on a Delphi Process

      Author(s): Bennett C; Vakil N; Bergman J; Harrison R; Odze R; Vieth M; Sanders S; Gay L; Pech O; Longcroft-Wheaton G; Romero Y; Inadomi J; Tack J; Corley DA; Manner H; Green S; Al Dulaimi D; Ali H; Allum B; Anderson M; Curtis H; Falk G; Fennerty MB; Fullarton G; Krishnadath K; Meltzer SJ; Armstrong D; Ganz R; Cengia G; Going JJ; Goldblum J; Gordon C; Grabsch H; Haigh C; Hongo M; Johnston D; Forbes-Young R; Kay E; Kaye P; Lerut T; Lovat LB; Lundell L; Mairs P; Shimoda T; Spechler S; Sontag S; Malfertheiner P; Murray I; Nanji M; Poller D; Ragunath K; Regula J; Cestari R; Shepherd N; Singh R; Stein HJ; Talley NJ; Galmiche JP; Tham TC; Watson P; Yerian L; Rugge M; Rice TW; Hart J; Gittens S; Hewin D; Hochberger J; Kahrilas P; Preston S; Sampliner R; Sharma P; Stuart R; Wang K; Waxman I; Abley C; Loft D; Penman I; Shaheen NJ; Chak A; Davies G; Dunn L; Falck-Ytter Y; Decaestecker J; Bhandari P; Ell C; Griffin SM; Attwood S; Barr H; Allen J; Ferguson MK; Moayyedi P; Jankowski JA

      Gastroenterology. 2012 Aug;143(2):336-46. Epub 2012 Apr 24.

      PubMed abstract

      The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on imaging in Barrett's Esophagus

      Author(s): Sharma P; Savides TJ; Canto MI; Corley DA; Falk GW; Goldblum JR; Wang KK; Wallace MB; Wolfsen HC

      Gastrointest Endosc. 2012 Aug;76(2):252-4.

      PubMed abstract

      Diabetes, Hypertension and Hyperlipidemia: Prevalence Over Time and Impact on Long-Term Survival After Liver Transplantation

      Author(s): Parekh J; Corley DA; Feng S

      Am J Transplant. 2012 Aug;12(8):2181-7. Epub 2012 Apr 30.

      PubMed abstract

      The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett's Esophagus and Esophageal Adenocarcinoma Consortium

      Author(s): Lubin JH; Cook MB; Pandeya N; Vaughan TL; Abnet CC; Giffen C; Webb PM; Murray LJ; Casson AG; Risch HA; Ye W; Kamangar F; Bernstein L; Sharp L; Nyren O; Gammon MD; Corley DA; Wu AH; Brown LM; Chow WH; Ward MH; Freedman ND; Whiteman DC

      Cancer Epidemiol. 2012 Jun;36(3):306-16. Epub 2012 Apr 13.

      PubMed abstract

      Cigarette Smoking Increases Risk of Barrett's Esophagus: an Analysis of the Barrett's and Esophageal Adenocarcinoma Consortium

      Author(s): Cook MB; Shaheen NJ; Anderson LA; Giffen C; Chow WH; Vaughan TL; Whiteman DC; Corley DA

      Gastroenterology. 2012 Apr;142(4):744-53. Epub 2012 Jan 11.

      PubMed abstract

      Does increased experience with laparoscopic cholecystectomy yield more complex bile duct injuries?

      Author(s): Chuang KI; Corley D; Postlethwaite DA; Merchant M; Harris HW

      Am J Surg. 2012 Apr;203(4):480-7. Epub 2012 Feb 9.

      PubMed abstract

      Non-Steroidal Anti-Inflammatory Drug Use Reduces Risk for Adenocarcinomas of the Esophagus and Esophagogastric Junction in a Pooled Analysis

      Author(s): Liao LM; Vaughan TL; Corley DA; Cook MB; Casson AG; Kamangar F; Abnet CC; Risch HA; Giffen C; Freedman ND; Chow WH; Sadeghi S; Pandeya N; Whiteman DC; Murray LJ; Bernstein L; Gammon MD; Wu AH

      Gastroenterology. 2012 Mar;142(3):442-452.e5; quiz e22-3. Epub 2011 Nov 19.

      PubMed abstract

      The Future of Colon Cancer Screening: What Do We Recommend and Will It Be Too Much, Too Little, or Just Right?

      Author(s): Corley DA

      Gastroenterology. 2011 Dec;141(6):1956-8. Epub 2011 Oct 21.

      PubMed abstract

      Is Diabetes Mellitus an Independent Risk Factor for Colon Cancer and Rectal Cancer?

      Author(s): Yuhara H; Steinmaus C; Cohen SE; Corley DA; Tei Y; Buffler PA

      Am J Gastroenterol. 2011 Nov;106(11):1911-21; quiz 1922. Epub 2011 Sep 13.

      PubMed abstract

      Can we improve adenoma detection rates? A systematic review of intervention studies

      Author(s): Corley DA; Jensen CD; Marks AR

      Gastrointest Endosc. 2011 Sep;74(3):656-65. Epub 2011 Jul 13.

      PubMed abstract

      Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium

      Author(s): Freedman ND; Murray LJ; Kamangar F; Abnet CC; Cook MB; Nyren O; Ye W; Wu AH; Bernstein L; Brown LM; Ward MH; Pandeya N; Green AC; Casson AG; Giffen C; Risch HA; Gammon MD; Chow WH; Vaughan TL; Corley DA; Whiteman DC

      Gut. 2011 Aug;60(8):1029-37. Epub 2011 Mar 14.

      PubMed abstract

      Understanding cancer incidence in Barrett's esophagus: light at the end of the tunnel

      Author(s): Corley DA

      J Natl Cancer Inst. 2011 Jul 6;103(13):994-5. Epub 2011 Jun 16.

      PubMed abstract

      Dietary factors and the risks of oesophageal adenocarcinoma and Barrett's oesophagus

      Author(s): Kubo A; Corley DA; Jensen CD; Kaur R

      Nutr Res Rev. 2010 Dec;23(2):230-46. Epub 2010 Jul 13.

      PubMed abstract

      Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium

      Author(s): Cook MB; Kamangar F; Whiteman DC; Freedman ND; Gammon MD; Bernstein L; Brown LM; Risch HA; Ye W; Sharp L; Pandeya N; Webb PM; Wu AH; Ward MH; Giffen C; Casson AG; Abnet CC; Murray LJ; Corley DA; Nyren O; Vaughan TL; Chow WH

      J Natl Cancer Inst. 2010 Sep 8;102(17):1344-53. Epub 2010 Aug 17.

      PubMed abstract

      Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients

      Author(s): Corley DA; Kubo A; Zhao W; Quesenberry C

      Gastroenterology. 2010 Jul;139(1):93-101. Epub 2010 Mar 27.

      PubMed abstract

      Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis

      Author(s): Cronin-Fenton DP; Murray LJ; Whiteman DC; Cardwell C; Webb PM; Jordan SJ; Corley DA; Sharp L; Lagergren J; Barrett's Esophagus ACBI

      Eur J Cancer. 2010 Jul;46(11):2067-76. Epub 2010 Apr 22.

      PubMed abstract

      Chemoprevention in Barrett's esophagus: are we there yet, are we there yet...?

      Author(s): Corley DA

      Clin Gastroenterol Hepatol. 2009 Dec;7(12):1266-8. Epub 2009 Sep 16.

      PubMed abstract

      Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States

      Author(s): Wong RJ; Corley DA

      Dig Dis Sci. 2009 Sep;54(9):2031-9. Epub 2009 Jan 1.

      PubMed abstract

      Alcohol types and sociodemographic characteristics as risk factors for Barrett's esophagus

      Author(s): Kubo A; Levin TR; Block G; Rumore GJ; Quesenberry CP Jr; Buffler P; Corley DA

      Gastroenterology. 2009 Mar;136(3):806-15. Epub 2008 Nov 27.

      PubMed abstract

      Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006

      Author(s): Corley DA; Kubo A; Levin TR; Block G; Habel L; Rumore G; Quesenberry C; Buffler P

      Gut. 2009 Feb;58(2):182-8. Epub 2008 Oct 31.

      PubMed abstract

      Effects of dietary fiber, fats, and meat intakes on the risk of Barrett's esophagus

      Author(s): Kubo A; Block G; Quesenberry CP Jr; Buffler P; Corley DA

      Nutr Cancer. 2009;61(5):607-16.

      PubMed abstract

      Hemochromatosis gene status as a risk factor for Barrett's esophagus

      Author(s): Corley DA; Kubo A; Levin TR; Block G; Habel L; Rumore GJ; Quesenberry C; Buffler P

      Dig Dis Sci. 2008 Dec;53(12):3095-102. Epub 2008 May 10.

      PubMed abstract

      Helicobacter pylori and gastroesophageal reflux disease: a case-control study

      Author(s): Corley DA; Kubo A; Levin TR; Block G; Habel L; Rumore G; Quesenberry C; Buffler P; Parsonnet J

      Helicobacter. 2008 Oct;13(5):352-60.

      PubMed abstract

      Dietary antioxidants, fruits, and vegetables and the risk of Barrett's esophagus

      Author(s): Kubo A; Levin TR; Block G; Rumore GJ; Quesenberry CP Jr; Buffler P; Corley DA

      Am J Gastroenterol. 2008 Jul;103(7):1614-23; quiz 1624.

      PubMed abstract

      Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study

      Author(s): Corley DA; Kubo A; Levin TR; Block G; Habel L; Zhao W; Leighton P; Rumore G; Quesenberry C; Buffler P; Parsonnet J

      Gut. 2008 Jun;57(6):727-33. Epub 2007 Sep 25.

      PubMed abstract

      Racial and ethnic variations in hepatocellular carcinoma incidence within the United States

      Author(s): Wong R; Corley DA

      Am J Med. 2008 Jun;121(6):525-31.

      PubMed abstract

      Cancer incidence in Barrett's esophagus: does it really matter, and who's counting anyway?

      Author(s): Corley DA

      Gastrointest Endosc. 2008 Mar;67(3):399-401.

      PubMed abstract

      Current surveillance and therapeutic options for barrett esophagus

      Author(s): Douglas C

      Gastroenterol Hepatol (N Y). 2008 Mar;4(3):183-6.

      PubMed abstract

      Abdominal obesity and the risk of esophageal and gastric cardia carcinomas

      Author(s): Corley DA; Kubo A; Zhao W

      Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):352-8.

      PubMed abstract

      Obesity and the rising incidence of oesophageal and gastric adenocarcinoma: what is the link?

      Author(s): Corley DA

      Gut. 2007 Nov;56(11):1493-4.

      PubMed abstract

      Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California

      Author(s): Mahadevan U; Sandborn WJ; Li DK; Hakimian S; Kane S; Corley DA

      Gastroenterology. 2007 Oct;133(4):1106-12. Epub 2007 Jul 25.

      PubMed abstract

      Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms

      Author(s): Corley DA; Kubo A; Zhao W

      Gut. 2007 Jun;56(6):756-62. Epub 2006 Oct 17.

      PubMed abstract

      Serum ghrelin levels and risk of subsequent adenocarcinoma of the esophagus

      Author(s): de Martel C; Haggerty TD; Corley DA; Vogelman JH; Orentreich N; Parsonnet J

      Am J Gastroenterol. 2007 Jun;102(6):1166-72. Epub 2007 Mar 22.

      PubMed abstract

      New-onset diabetes and pancreatic cancer

      Author(s): Gupta S; Vittinghoff E; Bertenthal D; Corley D; Shen H; Walter LC; McQuaid K

      Clin Gastroenterol Hepatol. 2006 Nov;4(11):1366-72; quiz 1301. Epub 2006 Sep 1.

      PubMed abstract

      Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis

      Author(s): Corley DA; Kubo A

      Am J Gastroenterol. 2006 Nov;101(11):2619-28. Epub 2006 Sep 4.

      PubMed abstract

      Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis

      Author(s): Kubo A; Corley DA

      Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):872-8.

      PubMed abstract

      Barrett's esophagus and medications that relax the lower esophageal sphincter

      Author(s): Corley DA; Levin TR; Habel LA; Buffler PA

      Am J Gastroenterol. 2006 May;101(5):937-44.

      PubMed abstract

      Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma

      Author(s): de Martel C; Llosa AE; Farr SM; Friedman GD; Vogelman JH; Orentreich N; Corley DA; Parsonnet J

      J Infect Dis. 2005 Mar 1;191(5):761-7. Epub 2005 Jan 20.

      PubMed abstract

      Influence of site classification on cancer incidence rates: an analysis of gastric cardia carcinomas

      Author(s): Corley DA; Kubo A

      J Natl Cancer Inst. 2004 Sep 15;96(18):1383-7.

      PubMed abstract

      Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States

      Author(s): Kubo A; Corley DA

      Am J Gastroenterol. 2004 Apr;99(4):582-8.

      PubMed abstract

      Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial

      Author(s): Corley DA; Katz P; Wo JM; Stefan A; Patti M; Rothstein R; Edmundowicz S; Kline M; Mason R; Wolfe MM

      Gastroenterology. 2003 Sep;125(3):668-76.

      PubMed abstract

      How should we select health professionals for studies?

      Author(s): Verma R; Corley DA

      Outcomes Manag. 2003 Jul-Sep;7(3):129-33.

      PubMed abstract

      Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis

      Author(s): Corley DA; Kerlikowske K; Verma R; Buffler P

      Gastroenterology. 2003 Jan;124(1):47-56.

      PubMed abstract

      Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States

      Author(s): Kubo A; Corley DA

      Cancer. 2002 Nov 15;95(10):2096-102.

      PubMed abstract

      Surveillance and survival in Barrett's adenocarcinomas: a population-based study

      Author(s): Corley DA; Levin TR; Habel LA; Weiss NS; Buffler PA

      Gastroenterology. 2002 Mar;122(3):633-40.

      PubMed abstract

      Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database

      Author(s): Corley DA; Buffler PA

      Int J Epidemiol. 2001 Dec;30(6):1415-25.

      PubMed abstract